{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:33:08Z","timestamp":1789443188632,"version":"build-2803163510"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mpa.0b013e31823f429f","type":"journal-article","created":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T07:22:47Z","timestamp":1332573767000},"page":"904-909","source":"Crossref","is-referenced-by-count":15,"title":["SLC5A8 Nuclear Translocation and Loss of Expression are Associated With Poor Outcome in Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1097","volume":"41","author":[{"given":"James","family":"Helm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadivel","family":"Ganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dung-Tsa","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mokenge P.","family":"Malafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Y.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":". Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R2-13-20210212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1208\/s12248-008-9022-y","article-title":". Sodium-coupled monocarboxylate transporters in normal tissues and in cancer.","volume":"10","author":"Ganapathy","year":"2008","journal-title":"AAPS J"},{"key":"R3-13-20210212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol Ther"},{"key":"R4-13-20210212","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s11095-006-9176-1","article-title":". Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.","volume":"24","author":"Gopal","year":"2007","journal-title":"Pharm Res"},{"key":"R5-13-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1471-4159.2006.03878.x","article-title":". Identity of SMCT1 (SLC5A8) as a neuron-specific Na-coupled transporter for active uptake of L-lactate and ketone bodies in the brain.","volume":"98","author":"Martin","year":"2006","journal-title":"J Neurochem"},{"key":"R6-13-20210212","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/j.lfs.2005.10.028","article-title":". SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter.","volume":"78","author":"Gupta","year":"2006","journal-title":"Life Sci"},{"key":"R7-13-20210212","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1158\/0008-5472.CAN-06-1950","article-title":". SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases.","volume":"66","author":"Thangaraju","year":"2006","journal-title":"Cancer Res"},{"key":"R8-13-20210212","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1073\/pnas.1430846100","article-title":". SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.","volume":"100","author":"Li","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R9-13-20210212","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1158\/0008-5472.CAN-05-0048","article-title":". Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8.","volume":"65","author":"Hong","year":"2005","journal-title":"Cancer Res"},{"key":"R10-13-20210212","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/modpathol.3800261","article-title":". Progressive methylation during the serrated neoplasia pathway of the colorectum.","volume":"18","author":"Dong","year":"2005","journal-title":"Mod Pathol"},{"key":"R11-13-20210212","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1073\/pnas.0602365103","article-title":". Na()monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT.","volume":"103","author":"Paroder","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-13-20210212","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1210\/jc.2004-1394","article-title":". Silencing of the tumor suppressor gene SLC5A8 is associated with BRAF mutations in classical papillary thyroid carcinomas.","volume":"90","author":"Porra","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R14-13-20210212","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.22110","article-title":". Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer.","volume":"119","author":"Hu","year":"2006","journal-title":"Int J Cancer"},{"key":"R15-13-20210212","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1089\/thy.2006.16.633","article-title":". CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma.","volume":"16","author":"Schagdarsurengin","year":"2006","journal-title":"Thyroid"},{"key":"R16-13-20210212","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1210\/en.2006-0927","article-title":"Gene methylation in thyroid tumorigenesis.","volume":"148","author":"Xing","year":"2007","journal-title":"Endocrinology"},{"key":"R17-13-20210212","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000079145","article-title":". Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.","volume":"25","author":"Ueno","year":"2004","journal-title":"Tumour Biol"},{"key":"R18-13-20210212","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/CBM-2005-12-307","article-title":". CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis.","volume":"1","author":"Park","year":"2005","journal-title":"Cancer Biomark"},{"key":"R19-13-20210212","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cdp.2007.09.002","article-title":". Candidate tumor suppressor gene SLC5A8 is frequently down-regulated by promoter hypermethylation in prostate tumor.","volume":"31","author":"Park","year":"2007","journal-title":"Cancer Detect Prev"},{"key":"R20-13-20210212","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-07-6509","article-title":". Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma.","volume":"68","author":"Bennett","year":"2008","journal-title":"Cancer Res"},{"key":"R21-13-20210212","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood-2008-01-128595","article-title":". DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.","volume":"112","author":"Whitman","year":"2008","journal-title":"Blood"},{"key":"R22-13-20210212","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/MPA.0b013e3181630ffe","article-title":". Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer.","volume":"36","author":"Park","year":"2008","journal-title":"Pancreas"},{"key":"R23-13-20210212","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1177\/107327480801500403","article-title":". Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution.","volume":"15","author":"Helm","year":"2008","journal-title":"Cancer Control"},{"key":"R24-13-20210212","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1002\/cncr.24503","article-title":". Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.","volume":"115","author":"Helm","year":"2009","journal-title":"Cancer"},{"key":"R25-13-20210212","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1158\/1078-0432.CCR-0157-03","article-title":". Prognostic and diagnostic significance of beta-catenin nuclear immunostaining in colorectal cancer.","volume":"10","author":"Wong","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R26-13-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.oraloncology.2011.01.004","article-title":". Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.","volume":"47","author":"Li","year":"2011","journal-title":"Oral Oncol"},{"key":"R27-13-20210212","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cancergencyto.2010.05.005","article-title":"Deletion mapping of chromosome region 12q13-24 in colorectal cancer.","volume":"201","author":"Aytekin","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"R28-13-20210212","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.271.5247.350","article-title":". DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.","volume":"271","author":"Hahn","year":"1996","journal-title":"Science"},{"key":"R29-13-20210212","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/modpathol.2008.62","article-title":". Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.","volume":"21","author":"Kloth","year":"2008","journal-title":"Mod Pathol"},{"key":"R30-13-20210212","first-page":"812","article-title":". Expression of the tumor suppressor gene Maspin in human pancreatic cancers.","volume":"7","author":"Maass","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R31-13-20210212","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00129039-200203000-00011","article-title":"Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis.","volume":"10","author":"Oh","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R32-13-20210212","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.3800772","article-title":". Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.","volume":"20","author":"Cao","year":"2007","journal-title":"Mod Pathol"},{"key":"R33-13-20210212","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1042\/BST0330237","article-title":". Biological functions of SLC5A8, a candidate tumour suppressor.","volume":"33","author":"Ganapathy","year":"2005","journal-title":"Biochem Soc Trans"},{"key":"R34-13-20210212","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1002\/cncr.24532","article-title":". Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.","volume":"115","author":"Thangaraju","year":"2009","journal-title":"Cancer"},{"key":"R35-13-20210212","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cancergencyto.2009.09.004","article-title":". Identification and characterization of the human SLC5A8 gene promoter.","volume":"196","author":"Zhang","year":"2010","journal-title":"Cancer Genet Cytogenet"},{"key":"R36-13-20210212","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.biocel.2010.08.007","article-title":". Activin A induces SLC5A8 expression through the Smad3 signaling pathway in human colon cancer RKO cells.","volume":"42","author":"Zhang","year":"2010","journal-title":"Int J Biochem Cell Biol"}],"container-title":["Pancreas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006676-201208000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:37:08Z","timestamp":1786048628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006676-201208000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mpa.0b013e31823f429f","relation":{},"ISSN":["0885-3177"],"issn-type":[{"value":"0885-3177","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}